Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists.

Hernández-Ruiz J, Salaiza-Suazo N, Carrada G, Escoto S, Ruiz-Remigio A, Rosenstein Y, Zentella A, Becker I.

PLoS Negl Trop Dis. 2010 Nov 2;4(11):e871. doi: 10.1371/journal.pntd.0000871.

2.

Monocyte cytokine and costimulatory molecule expression in patients infected with Leishmania mexicana.

Carrada G, Cañeda C, Salaiza N, Delgado J, Ruiz A, Sanchez B, Gutiérrez-Kobeh L, Aguirre M, Becker I.

Parasite Immunol. 2007 Mar;29(3):117-26.

3.

NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.

Cañeda-Guzmán IC, Salaiza-Suazo N, Fernández-Figueroa EA, Carrada-Figueroa G, Aguirre-García M, Becker I.

PLoS One. 2014 Nov 14;9(11):e112410. doi: 10.1371/journal.pone.0112410. eCollection 2014.

4.

[Immunopathology of American tegumentary leishmaniasis].

Castés M, Tapia FJ.

Acta Cient Venez. 1998;49(1):42-56. Review. Spanish.

PMID:
10205916
5.

Vaccination with Leishmania mexicana LPG induces PD-1 in CD8⁺ and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy.

Martínez Salazar MB, Delgado Domínguez J, Silva Estrada J, González Bonilla C, Becker I.

Vaccine. 2014 Mar 5;32(11):1259-65. doi: 10.1016/j.vaccine.2014.01.016. Epub 2014 Jan 23.

6.

The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production.

Tapia FJ, Caceres-Dittmar G, Sanchez MA, Fernandez AE, Convit J.

Biol Res. 1993;26(1-2):239-47.

PMID:
7545501
7.

Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion.

Diaz NL, Zerpa O, Ponce LV, Convit J, Rondon AJ, Tapia FJ.

Exp Dermatol. 2002 Feb;11(1):34-41.

PMID:
11952826
8.

Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity.

França-Costa J, Wanderley JL, Deolindo P, Zarattini JB, Costa J, Soong L, Barcinski MA, Barral A, Borges VM.

PLoS One. 2012;7(5):e36595. doi: 10.1371/journal.pone.0036595. Epub 2012 May 4.

10.

Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis.

Ritter U, Moll H, Laskay T, Bröcker E, Velazco O, Becker I, Gillitzer R.

J Infect Dis. 1996 Mar;173(3):699-709.

PMID:
8627035
11.
12.

Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis.

Mengistu G, Akuffo HO, Yemane-Berhan T, Britton S, Fehniger TE.

Parasite Immunol. 1990 Sep;12(5):495-507.

PMID:
2255561
13.

Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis.

Qadoumi M, Becker I, Donhauser N, Röllinghoff M, Bogdan C.

Infect Immun. 2002 Aug;70(8):4638-42.

14.

Responsiveness in diffuse versus local cutaneous leishmaniasis is due to parasite differences.

Akuffo H, Schurr E, Andersson G, Yamaneberhan T, Britton S.

Scand J Immunol. 1987 Dec;26(6):717-21.

PMID:
3122314
15.

Disease severity in patients infected with Leishmania mexicana relates to IL-1β.

Fernández-Figueroa EA, Rangel-Escareño C, Espinosa-Mateos V, Carrillo-Sánchez K, Salaiza-Suazo N, Carrada-Figueroa G, March-Mifsut S, Becker I.

PLoS Negl Trop Dis. 2012;6(5):e1533. doi: 10.1371/journal.pntd.0001533. Epub 2012 May 22.

17.

Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome.

Salaiza-Suazo N, Volkow P, Tamayo R, Moll H, Gillitzer R, Pérez-Torres A, Pérez-Montfort R, Domínguez JD, Velasco-Castrejón O, Crippa M, Becker I.

Trop Med Int Health. 1999 Dec;4(12):801-11.

18.
19.

Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis.

Campanelli AP, Brodskyn CI, Boaventura V, Silva C, Roselino AM, Costa J, Saldanha AC, de Freitas LA, de Oliveira CI, Barral-Netto M, Silva JS, Barral A.

Hum Immunol. 2010 Dec;71(12):1220-7. doi: 10.1016/j.humimm.2010.09.002. Epub 2010 Sep 18.

PMID:
20854864
20.

Supplemental Content

Support Center